Abstract：
OBJECTIVE: To determine whether balloon dilation of Eustachian tube (BDET) improves postoperative audiology and quality of life scores in children with chronic Eustachian tube dysfunction.
METHODS: Retrospective study.
METHODS: Tertiary care pediatric center.
METHODS: Eligible participants were patients 8 years or older, with a history of 2 prior tubes placement. Group 1-patients completed pre-and post-Eustachian Tube Dysfunction Quality of Life Survey (ETDQ-7) survey scores, Group 2-patients had available pre- and postdilation tympanogram data (TD), and Group 3-patients had both ETDQ-7 survey and TD. The average time for the first and subsequent follow-ups was 3.8 and 12.9 months, respectively.
RESULTS: A total of 43 patients (85 ears) underwent BDET. The mean age was 13.3 years (8-18 years). Twenty-four patients were male (55.8%) and over 80% were Caucasian. The average mean ETDQ-7 score before and after dilation was 3.9 and 2.5, respectively. Ninety-three percent experienced improvement of their postoperative ETDQ-7 scores and 53% had normal postdilation ETDQ-7 score (P < .0001). Thirty-seven ears in Group 2 (60.7%) had improvement in postdilation TD. A greater proportion of ears showed improvement of 62.3% with a 95% confidence interval (CI) [50.1%-74.5%] compared to 37.7% without improvement, 95% CI [25.5%-49.87%]. Ears with type A or B TD were more likely to show improvement than ears with type C, perforated, or with tubes (P < .0001). Eighteen out of 30 ears in Group 3 (60%) experienced an improvement in both ETDQ-7 and tympanogram.
CONCLUSIONS: BDET is a safe, efficacious alternative to tubes in selected pediatric patients.
METHODS: Retrospective study.
METHODS: Tertiary care pediatric center.
METHODS: Eligible participants were patients 8 years or older, with a history of 2 prior tubes placement. Group 1-patients completed pre-and post-Eustachian Tube Dysfunction Quality of Life Survey (ETDQ-7) survey scores, Group 2-patients had available pre- and postdilation tympanogram data (TD), and Group 3-patients had both ETDQ-7 survey and TD. The average time for the first and subsequent follow-ups was 3.8 and 12.9 months, respectively.
RESULTS: A total of 43 patients (85 ears) underwent BDET. The mean age was 13.3 years (8-18 years). Twenty-four patients were male (55.8%) and over 80% were Caucasian. The average mean ETDQ-7 score before and after dilation was 3.9 and 2.5, respectively. Ninety-three percent experienced improvement of their postoperative ETDQ-7 scores and 53% had normal postdilation ETDQ-7 score (P < .0001). Thirty-seven ears in Group 2 (60.7%) had improvement in postdilation TD. A greater proportion of ears showed improvement of 62.3% with a 95% confidence interval (CI) [50.1%-74.5%] compared to 37.7% without improvement, 95% CI [25.5%-49.87%]. Ears with type A or B TD were more likely to show improvement than ears with type C, perforated, or with tubes (P < .0001). Eighteen out of 30 ears in Group 3 (60%) experienced an improvement in both ETDQ-7 and tympanogram.
CONCLUSIONS: BDET is a safe, efficacious alternative to tubes in selected pediatric patients.
摘要：
目的：确定咽鼓管球囊扩张（BDET）是否可以改善慢性咽鼓管功能障碍患儿的术后听力学和生活质量评分。
方法：回顾性研究。
方法：三级护理儿科中心。
方法：符合条件的参与者是8岁或以上的患者，具有2个先前的管放置的历史。第1组患者完成咽鼓管功能障碍前后生活质量调查（ETDQ-7）调查评分，第2组患者有可用的扩张前后鼓室图数据（TD），第3组患者进行了ETDQ-7调查和TD。第一次及以后的平均随访时间分别为3.8个月和12.9个月,分别。
结果：共有43例（85耳）患者接受了BDET。平均年龄为13.3岁（8-18岁）。24例患者为男性（55.8%），超过80%为白种人。扩张前后平均ETDQ-7评分分别为3.9和2.5。93％的患者术后ETDQ-7评分有所改善，53％的患者术后ETDQ-7评分正常（P<0.0001）。第2组中的37只耳朵（60.7％）在扩张后TD方面有所改善。与没有改善的37.7％相比，耳朵的比例更高，改善了62.3％，置信区间（CI）为95％[50.1％-74.5％]。95%CI[25.5%-49.87%]。A型或B型TD的耳朵比C型耳朵更有可能表现出改善，穿孔,或管（P<0.0001）。第3组的30只耳朵中有18只（60％）的ETDQ-7和鼓室图都有所改善。
结论：BDET是一种安全的，在选定的儿科患者中有效替代管。
方法：回顾性研究。
方法：三级护理儿科中心。
方法：符合条件的参与者是8岁或以上的患者，具有2个先前的管放置的历史。第1组患者完成咽鼓管功能障碍前后生活质量调查（ETDQ-7）调查评分，第2组患者有可用的扩张前后鼓室图数据（TD），第3组患者进行了ETDQ-7调查和TD。第一次及以后的平均随访时间分别为3.8个月和12.9个月,分别。
结果：共有43例（85耳）患者接受了BDET。平均年龄为13.3岁（8-18岁）。24例患者为男性（55.8%），超过80%为白种人。扩张前后平均ETDQ-7评分分别为3.9和2.5。93％的患者术后ETDQ-7评分有所改善，53％的患者术后ETDQ-7评分正常（P<0.0001）。第2组中的37只耳朵（60.7％）在扩张后TD方面有所改善。与没有改善的37.7％相比，耳朵的比例更高，改善了62.3％，置信区间（CI）为95％[50.1％-74.5％]。95%CI[25.5%-49.87%]。A型或B型TD的耳朵比C型耳朵更有可能表现出改善，穿孔,或管（P<0.0001）。第3组的30只耳朵中有18只（60％）的ETDQ-7和鼓室图都有所改善。
结论：BDET是一种安全的，在选定的儿科患者中有效替代管。
